The Pharma Letter Podcast — Episode 6 — Patient empowerment and multiple sclerosis

Simon Wentworth

1 November 2021

janssen_podcast

More on this story...

Multiple sclerosis treatment fails to impress in mid-stage trial

21 March 2022

F-star Therapeutics bags $1.5 billion deal with Janssen

20 October 2021

Janssen receives MHRA authorization for Ponvory in RMS

11 August 2021

Mestag teams up with Janssen in inflammatory disease

18 May 2021

Related company news

Carvykti scores well in landmark CARTITUDE-4 study

Another win for nipocalimab as J&J closes in on rivals

FDA greenlight for Samsung Bioepis’ biosimilar to Stelara

J&J moves Rybrevant into first-line setting with full EU approval

More ones to watch >

More Features in Pharmaceutical

Access to medicines key to British voters, survey shows

3 July 2024

Pentixapharm pads pipeline with strategic acquisition

3 July 2024

Striking results in Phase III Parkinson’s trial

3 July 2024

ThirtyFiveBio receives grant to continue work on GPR35 blockers

2 July 2024

Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze